Connecticut 2015 Regular Session

Connecticut House Bill HB06292 Latest Draft

Bill / Introduced Version Filed 01/21/2015

                            General Assembly  Proposed Bill No. 6292
January Session, 2015  LCO No. 1457
 *01457*
Referred to Committee on PUBLIC HEALTH
Introduced by:
REP. CANDELORA, 86th Dist. REP. KOKORUDA, 101st Dist.

General Assembly

Proposed Bill No. 6292 

January Session, 2015

LCO No. 1457

*01457*

Referred to Committee on PUBLIC HEALTH 

Introduced by:

REP. CANDELORA, 86th Dist.

REP. KOKORUDA, 101st Dist.

AN ACT CONCERNING THE "RIGHT TO TRY" INVESTIGATIONAL TREATMENTS AND DRUGS.

Be it enacted by the Senate and House of Representatives in General Assembly convened:

That the general statutes be amended to allow (1) terminally ill patients to request access to treatment and drugs that have passed the first clinical trial stage of development but have not received final approval by the federal Food and Drug Administration, and (2) physicians, hospitals and manufacturers of investigational drugs, products and devices to make such treatment, drugs, products and devices available to terminally ill patients without being subject to prosecution. 

Statement of Purpose: 

To allow terminally ill patients the "right to try" experimental treatments and drugs.